Gracie McGraw said that using the weight-loss medication Ozempic triggered a relapse of her eating disorder [1].
McGraw is the daughter of country music stars Tim McGraw and Faith Hill. Her public account highlights the potential psychological risks associated with rapid weight-loss drugs, even when prescribed for medical conditions.
In a series of Instagram Stories posted on Aug. 3, 2026 [1], McGraw said the drug's effects revived pre-existing body-image issues and disordered eating behaviors [1]. She noted that the medication was intended to help with her polycystic ovary syndrome (PCOS) [2], though some reports refer to the condition as polyendocrine metabolic ovarian syndrome (PMOS) [1].
"I thought Ozempic would help with my PCOS symptoms, but it just made my relationship with food worse," McGraw said [2].
She said that the rapid physical changes led her to believe she was successfully managing her health while actually regressing into old patterns. The pressure of societal beauty standards played a role in this shift, according to her posts.
"All of a sudden skinny culture is back and I realized holy crap I have been feeding into my eating disorder this whole time under the guise of this miracle shot," McGraw said [1].
McGraw's experience comes amid a broader global surge in the use of GLP-1 receptor agonists for both diabetes and weight management. While these drugs are clinically proven to reduce weight, health professionals have cautioned that they do not address the underlying psychological drivers of eating disorders. By masking hunger, the drugs can potentially hide the onset of restrictive behaviors until they become severe.
Her statement was reported by various U.S. entertainment outlets on Aug. 4 and Aug. 5, 2026 [1, 2].
“"I thought Ozempic would help with my PCOS symptoms, but it just made my relationship with food worse."”
This account underscores a growing concern among medical practitioners regarding the intersection of pharmacological weight loss and mental health. When medications like Ozempic provide rapid results, they may inadvertently validate disordered eating patterns or 'skinny culture' for those with a history of eating disorders. This suggests a need for integrated psychiatric screening and support alongside the prescription of GLP-1 medications to ensure physical weight loss does not come at the cost of psychological stability.
